OneMedForum to Highlight the Newest, Most Promising Med Tech Innovations
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
regenerative medicine
RepRegen’s Platform for Bone and Tissue Regeneration
RepRegen, formerly known as BioCeramic Therapeutics, is developing a repair and regeneration technology platform designed to mend and repair hard tissue such as bone and soft tissue such as cartilage.
Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
Cytori Therapeutics is a leading global innovator in the emerging field of regenerative medicine using adipose (fat) tissue as a rich source of adult stem cells capable of differentiating into a variety of cell types.
Cytori’s Cardiac Celution: Encouraging Interim Data
In the area of heart disease, Cytori Therapeutics (NASDAQ: CYTX) is sponsoring two European clinical trials that evaluate the use of adipose-derived stem and regenerative cells (ADRCs) to treat acute myocardial infarction and chronic myocardial ischemia.